BPA for hetlioz
Ended Awarded Last action
- Contract number
- 36E79722A0028
- Awardee
-
Vanda Pharmaceuticals Inc. UEI NG5JU1TQ3379
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $3,069,780.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Vanda Pharmaceuticals Inc. (Vanda) on October 26, 2022. The single-award BPA has a ceiling value of $3,069,780 and a period of performance through August 31, 2024. The BPA is for the procurement of Hetlioz (tasimelteon), a medication used to treat Non-24-Hour Sleep-Wake Disorder in blind adults and patients with Smith-Magenis Syndrome. Vanda is the manufacturer of Hetlioz and has a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The BPA allows the Department of Veterans Affairs (VA) to efficiently order and receive Hetlioz to meet the needs of eligible veterans, as the VA has recognized Vanda as a key supplier of this specialized pharmaceutical. In addition to this BPA, Vanda has received numerous individual delivery orders from various VA agencies, particularly the Veterans Integrated Service Networks (VISNs), for Hetlioz, with contract values ranging from approximately $20,000 to $162,000 per order. These awards are not designated as set-asides, reflecting Vanda's unique position as the sole manufacturer of Hetlioz.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722A0028?
36E79722A0028 was awarded to Vanda Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 26, 2022.
How much is contract 36E79722A0028 worth?
36E79722A0028's own ceiling is $3,069,780.
Who can order from contract 36E79722A0028?
36E79722A0028 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0028 under another contract?
Yes. 36E79722A0028 is a blanket purchase agreement under V797D70102, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0028 competed?
The extent of competition for 36E79722A0028 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV